Skip to main content

Featured

Farmers’ Fury Erupts in Greece Over EU Subsidy Delays

                                         Protesting farmers push against riot police in Nikaia, near Larissa, Greece    Greek farmers clashed with police on Sunday in central and northern regions of the country as anger mounted over the delayed payment of European Union agricultural subsidies. The protests, centered around Nikaia near Larissa, saw hundreds of farmers blocking highways with tractors and demanding immediate government action. The unrest stems from an estimated €600 million shortfall in EU aid following a corruption scandal that has triggered investigations by the European Public Prosecutor’s Office. Authorities allege that some farmers falsified land and livestock ownership records to secure subsidies, leading to a freeze in payments while the probe continues. Police responded with tear gas and barricades as demonstrators attempted to...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment